This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levy, R. Articles by Sela, M. Search for Related Content PubMed PubMed Citation Articles by Levy, R. Articles by Sela, M.

The Specific Cytotoxic Effects of Daunomycin Conjugated to Antitumor Antibodies

Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel

Daunomycin was covalently bound to immunoglobulins by periodate oxidation as described in the preceding paper. Conjugates were prepared with immunoglobulins directed against either of two mouse lymphoid tumors or with nonspecific immunoglobulins. These conjugates were tested for their toxic effects on various tumor target cells as measured either by their inhibition of RNA synthesis or by their reduction of the growth of the tumor cells after transplantation. We found that the drug preferentially affected the target cells that the antibody to which it was attached could recognize. These daunomycin-antibody conjugates are therefore sufficiently toxic and selective in their effects to be potentially useful in in vivo therapeutic studies.

¹ Fellow of the Helen Hay Whitney Foundation. Permanent address: Department of Medical Oncology, Stanford Medical School, Stanford, Calif.

Received 11/ 4/74. Accepted 1/20/75.

This article has been cited by other articles:

				M. Sela From Proteins and Protein Models to Their Use in Immunology and Immunotherapy J. Biol. Chem., December 5, 2003; 278(49): 48507 - 48519. [Full Text] [PDF]

				N. Seo, Y. Tokura, M. Takigawa, and K. Egawa Depletion of IL-10- and TGF-{beta}-Producing Regulatory {gamma}{delta} T Cells by Administering a Daunomycin-Conjugated Specific Monoclonal Antibody in Early Tumor Lesions Augments the Activity of CTLs and NK Cells J. Immunol., July 1, 1999; 163(1): 242 - 249. [Abstract] [Full Text] [PDF]